Selectis Health (GBCS) Long-Term Deferred Tax (2014 - 2021)

Selectis Health (GBCS) has 8 years of Long-Term Deferred Tax data on file, last reported at $4.2 million in Q4 2021.

• Quarterly Long-Term Deferred Tax rose 15.15% year-over-year to $4.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4.2 million (up 15.15% YoY) and the FY2021 annual result came in at $4.2 million, up 15.15% from the prior year.
• Long-Term Deferred Tax rose to $4.2 million in Q4 2021 per GBCS's latest filing, from $3.7 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $13.0 million in Q4 2018, with the low at $3.7 million in Q4 2020.
• Average Long-Term Deferred Tax over 5 years is $9.2 million, with a median of $12.4 million recorded in 2017.
• Year-over-year, Long-Term Deferred Tax slumped 70.86% in 2020 and grew 15.15% in 2021.
• Selectis Health's Long-Term Deferred Tax stood at $12.4 million in 2017, then gained by 4.59% to $13.0 million in 2018, then dropped by 3.08% to $12.6 million in 2019, then tumbled by 70.86% to $3.7 million in 2020, then gained by 15.15% to $4.2 million in 2021.
• Business Quant data shows GBCS's Long-Term Deferred Tax at $4.2 million in Q4 2021, $3.7 million in Q4 2020, and $12.6 million in Q4 2019.